Dashboard
Manage Tickers

BTCYBIOTRICITY INC.

Nasdaq biotricity.com


$ 0.07 (17.07 %)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.52 $ -0.60 (-0.12 %)
DIA $ 408.83 $ -0.40 (-0.1 %)
SPY $ 558.91 $ -1.02 (-0.18 %)
TLT $ 98.84 $ 0.16 (0.16 %)
GLD $ 231.90 $ 0.24 (0.1 %)
$ 0.48
-- x --
-- x --
-- - --
$ 0.37 - $ 0.76
139,531
na
9.35M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2024 06-30-2024 10-Q
2 06-27-2024 03-31-2024 10-K
3 02-20-2024 12-31-2023 10-Q
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 06-29-2023 03-31-2023 10-K
7 02-14-2023 12-31-2022 10-Q
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 07-14-2022 03-31-2022 10-K
11 02-14-2022 12-31-2021 10-Q
12 11-04-2021 09-30-2021 10-Q
13 08-17-2021 06-30-2021 10-Q
14 06-22-2021 03-31-2021 10-K
15 02-16-2021 12-31-2020 10-Q
16 11-13-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 07-15-2020 03-31-2020 10-K
19 02-14-2020 12-31-2019 10-Q
20 11-14-2019 09-30-2019 10-Q
21 08-15-2019 06-30-2019 10-Q
22 07-16-2019 03-31-2019 10-K
23 02-19-2019 12-31-2018 10-Q
24 11-14-2018 09-30-2018 10-Q
25 08-14-2018 06-30-2018 10-Q
26 07-13-2018 03-31-2018 10-K
27 02-14-2018 12-31-2017 10-Q
28 11-14-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 03-30-2017 12-31-2016 10-K
31 11-18-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 12-21-2015 11-30-2015 10-Q
35 11-30-2015 08-31-2015 10-K
36 07-14-2015 05-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biotricitys-ai-cloud-upgrades-drive-operational-gains-and-path-to-profitability
Biotricity's AI Cloud Upgrades Drive Opera...
07/22/2024 11:15:32

Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consu...

reported-earlier-biotricity-now-expects-to-reach-milestone-of-being-ebitda-positive-before-the-end-of-calendar-2024
Reported Earlier, Biotricity Now Expects T...
07/11/2024 15:58:27

Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consu...

biotricity-launches-instant-at-home-heart-health-screening-service-heartsecure
Biotricity Launches Instant At-Home Heart ...
06/28/2024 11:35:30

Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare indu...

biotricity-q4-2024-adj-eps-047-misses-036-estimate-sales-3200m-inline
Biotricity Q4 2024 Adj EPS $(0.47) Misses ...
06/27/2024 12:26:30

Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.36) ...

biotricity-q4-revenue-32m-up-159-yoy-eps-047
Biotricity Q4 Revenue $3.2M, Up 15.9% YoY,...
06/27/2024 12:19:55

biotricity-sees-year-end-revenue-growth-to-exceed-24-yoy-loss-from-operations-to-decrease-over-40-yoy-margins-to-improve-over-10-yoy
Biotricity Sees Year-End Revenue Growth To...
06/06/2024 13:21:22

biotricity-launches-direct-to-patient-cardiac-screening-service
Biotricity Launches Direct-to-Patient Card...
05/30/2024 13:20:08

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/16/2024 16:31:11

biotricity-announces-high-demand-for-its-lbiotres-pro-a-3-channel-patch-like-ecg-biotres-pro-is-expected-to-raise-the-average-subscription-price-by-over-32-translating-to-revenue-increase-of-up-to-10-from-sales-to-existing-customers-throughout-2025
Biotricity Announces High Demand For Its L...
04/26/2024 11:29:36

Biotres Pro Is Also Capturing The Attention Of New Customers. The Initial Production Run Of Biotres Pro Has Sold Out, With Cust...

biotricity-launches-cardiac-monitoring-pilot-program-in-a-hospital-system-comprised-of-9-hospitals-and-10-clinics
Biotricity Launches Cardiac Monitoring Pil...
04/18/2024 11:08:46

biotricity-launches-cardiac-monitoring-pilot-program-with-major-hospital-network
Biotricity Launches Cardiac Monitoring Pil...
04/16/2024 11:10:02

why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Ultragenyx Pharmaceutical Shares Are T...
04/15/2024 18:11:35

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

biotricity-says-it-is-continuing-strategic-expansion-with-its-latest-partnership-in-neurology-to-conduct-cardiac-screenings-in-patients-suffering-from-neurological-issues
Biotricity Says It Is Continuing Strategic...
04/02/2024 11:21:05

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
03/18/2024 17:31:33

biotricity-unveils-that-improved-margins-resulted-from-latest-advancements-to-its-proprietary-cardiac-ai-cloud-platform-and-announces-plans-for-continued-expansion-of-its-cardiac-ai-cloud
Biotricity Unveils That Improved Margins R...
03/12/2024 13:04:40

Biotricity's AI automation engine has already proven to increase operational efficiency and support growth, evidenced by th...

biotricity-receives-health-canada-clearance-for-biotres
Biotricity Receives Health Canada Clearanc...
02/29/2024 13:26:57

biotricity-q3-2024-adj-eps-012-beats-044-estimate-sales-297m-miss-300m-estimate
Biotricity Q3 2024 Adj EPS $(0.12) Beats $...
02/20/2024 23:14:16

Biotricity (NASDAQ:BTCY) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.44) by...

why-fluor-shares-are-trading-lower-by-around-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Fluor Shares Are Trading Lower By Arou...
02/20/2024 18:21:11

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

earnings-scheduled-for-february-20-2024
Earnings Scheduled For February 20, 2024
02/20/2024 11:52:12

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...

biotricitys-earnings-outlook
Biotricity's Earnings Outlook
02/19/2024 20:01:46

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION